Teva Pharma News
Teva pharmaceuticals news
Lincoln, Teva, PetMed: Fast-Growth Stocks
Lincoln, Teva, PetMed: Fast-Growth Stocks
TheStreet.com - 43 minutes ago
By Jake Lynch 11/02/09 - 09:21 AM EST BOSTON (TheStreet) -- These companies are projected to increase revenue and profit by at least 12% in the coming year and have "buy" ratings from our ...
Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
Reuters - 3 minutes ago
ALLEGAN, Mich., Nov. 2 /PRNewswire-FirstCall/ -- -- Fiscal first quarter revenue from continuing operations increased $72 million, or 16%, to $528 million -- Fiscal first quarter GAAP income from ...
Will Pfizer buy Protalix?
Will Pfizer buy Protalix?
Globes - 16 minutes ago
Will US pharmaceuticals giant Pfizer (NYSE: PFE) buy Israeli company Protalix Biotherapeutics Inc. (AMEX:PLX)? Representatives of Protalix have visited Protalix's plant in Carmiel in the past few ...
MultiGene Vascular Systems (MGVS) secures $8.5 million in venture funding round
MultiGene Vascular Systems (MGVS) secures $8.5 million in venture funding round
Trading Markets - 46 minutes ago
Oct 30, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- TEVA -- MultiGene Vascular Systems (MGVS), Ltd., an Israel-based developer of therapeutic products for heart and blood vessel ...
Israel Stocks
Israel Stocks
MarketWatch - 54 minutes ago
By Robert Daniel, MarketWatch TEL AVIV (MarketWatch) -- Israeli stocks declined for a third day, led by weakness in most of the banks as well as Israel Chemicals, Bezeq and Teva Pharmaceutical ...
Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
Trading Markets - 28 minutes ago
DALLAS, Oct 29, 2009 (GlobeNewswire via COMTEX) -- TEVA -- StockPreacher.com announces an investment report featuring Metabasis Therapeutics (Nasdaq:MBRX). The report includes financial and ...
Markets in Brief
Markets in Brief
Ha'aretz - 31 minutes ago
Bank Hapoalim is predicting that Teva Pharmaceutical Industries' third-quarter results will beat market expectations. Analyst Gilad Sarig predicts that in order to contend with an anticipated ...
